Remission Biome is our founding project. It started in early 2023 with a pilot program followed by an n=50 study nicknamed the Renegade 50. It uses antibiotics, probiotics, and other supplements, gut prep, safety tests, symptom and other tracking. Its goal is to trigger transient remission events and/or long term increases in baseline functioning in people with ME/CFS and Long Covid who may also have multiple co-morbidities. Participants include people from mild to severe.  

 

A Remission Biome data team analyst presented a PDF poster to the 2025 Keystone Conference in Santa Fe. See below for web friendly image.

See the Remission Biome website for more about this specific project and team.